These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2487420)

  • 1. [Immunoregulation of tumor growth in a murine model].
    de Bonaparte YP; Colombo L; Davel L; Diament M; Eiján AM; Jasnis MA; Klein S; de Kohan SS; Oisgold-Daga S; Stillitani I
    Medicina (B Aires); 1989; 49(3):265-70. PubMed ID: 2487420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the incidence of metastasis in tumor-resected mice. Influence of soluble tumor extract and splenectomy.
    Klein S; de Bonaparte YP; de D'Elia I
    Invasion Metastasis; 1985; 5(5):309-16. PubMed ID: 4030247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-induced angiogenesis: correlation with the metastatic incidence of two murine mammary adenocarcinomas.
    Miguez M; Davel L; de Lustig ES
    Invasion Metastasis; 1986; 6(5):313-20. PubMed ID: 2430911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro immune interferon induction during tumor evolution.
    Kohan S; Lustig ES; Teyssié AR; Tous M; Ayerra B
    Biomed Pharmacother; 1986; 40(4):150-3. PubMed ID: 3098317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y; Paul RD; Wang Y; Lopez DM
    J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
    Nicolson GL; Lembo TM; Welch DR
    Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A granulocytosis-inducing tumor inhibits the production of B lymphocytes in murine bone marrow.
    Fülöp G; Lee MY; Rosse C
    J Immunol; 1985 Dec; 135(6):4266-72. PubMed ID: 3877765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
    Frey AB
    J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system].
    Iunker VM; Arkhipov SA; Gruntenko EV
    Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cell infiltrate of the primary tumor as a source of early systemic protection against metastases in mice.
    Vaage J; Pepin KG
    J Natl Cancer Inst; 1983 Jul; 71(1):147-55. PubMed ID: 6345879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic activity by spleen cell supernatants from tumor-bearing and tumor-resected mice.
    Davel L; Miguez M; Jasnis MA; Eiján AM; Oisgold-Dagá S; Sacerdote de Lustig E
    J Surg Oncol; 1988 Jan; 37(1):44-8. PubMed ID: 2447442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.